Skip to main content
. 2013 Mar 27;2013:374170. doi: 10.1155/2013/374170

Table 1.

Hypervascular lesions in noncirrhotic patients. The most important elements to achieve the differential diagnosis.

MRI features
Risk factor and clinical setting T2w T1w in T1w out DWI Pre-c ArtP PVP EqP HBP Specific pattern
Inflammatory adenoma Hyper Hypo Hypo Restriction Hypo Hyper + Hyper Hyper/iso Hypo/hyper Signal heterogeneity, hypervascularity, intralesional hemorrhage
HNF-1α-mutated adenoma Obesity, steatosis, diabetes, glycogenesis, exogenous steroids Iso/hyper Hyper Hypo No restriction Iso/hypo Hyper Hypo Hypo Hypo Fatty intralesional component
β-catenin-mutated adenoma Hyper Hypo Hypo Restriction Hypo Hyper + Hyper Hyper/iso Hypo/hyper Intralesional hemorrhage, necrosis
Unclassified adenoma Nonspecific patterns reported
Focal nodular hyperplasia Exogenous steroids Iso Iso Iso No restriction Iso Hyper +++ Iso Iso Iso/hyper Signal homogeneity, hypervascularity, scar, iso/hyperintensity on HbP
Large regenerative nodule Myeloproliferative and lymphoproliferative disorders, chronic vascular and rheumatologic syndromes Iso Iso Iso No restriction Iso Hyper ++ Iso Iso Iso/hyper Multiple lesions signal homogeneity, hypervascularity, scar, isohyperintensity on HbP
HCC in noncirrhotic liver and FL-HCC Exogenous steroidenvironmental and dietary factors (aflatoxins and nitrosamine) Hyper Hypo Hypo Restriction Hypo Hyper ++ Hypo Hypo Hypo Signal heterogeneity, intralesional hemorrhage, signs of malignancy
Cholangiocarcinoma Viral hepatic infection Hyper Hypo Hypo Restriction Hypo Hyper Hypo Hypo/iso Hypo/hyper Peripheral enhancement, peripheral washout, central pooling, signs of malignancy
Primary lymphoma Epstein-Barr infection (EBV), HBV and/or HCV infections Iso/hyper Hypo Hypo Restriction Hypo Hyper Hypo Hypo Hypo Variable pattern, small lesions hypervascular, significant restriction
Metastases Primary tumor, metastatic syndrome Hyper Hypo Hypo Restriction Hypo Hyper ++ Iso/hypo Hypo Hypo Multiple lesions hypervascularity, halo signs signs of malignancy